Mountable Printable Placard With Headband
A resilient headband in a shape for being mounted on the head of the user. The headband is equipped with a longitudinal slotted member for holding a placard.
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 7432371 | Nanofilm and membrane compositions Nanofilms useful for filtration are prepared from oriented amphiphilic molecules and oriented macrocyclic modules. The amphiphilic species may be oriented on an interface or surface. The nanofilm may be prepared by depositing or attaching an oriented layer to a subs... | 10/07/2008 |
| 7321033 | 3-B-D-ribofuranosylthiazolo [4,5-] pyrimidine nucleosides and uses thereof The invention is directed to 3-β-D-ribofuranosylthiazolo[4,5-d]pyridimine nucleosides and pharmaceutical compositions containing such compounds that have immunomodulatory activity. The invention is also directed to the therapeutic or prophylactic use of such compou... | 01/22/2008 |
| 7279575 | Pyrimidylpyrrole derivatives active as kinase inhibitors Pyrimidylpyrrole derivatives of formula (I) and pharmaceutically acceptable salts thereof, as defined in the specification, process for their preparation and pharmaceutical compositions comprising them are disclosed; the compounds of the invention may be useful, in ... | 10/09/2007 |
| 7226926 | 8-fluoroimidazo 1,2-a pyridine derivatives as ligands for GABA receptors A class of 8-fluoroimidazo[1,2-α]pyridine derivatives, substituted at the 3-position by an optionally substituted five-membered or six-membered heteroaromatic ring, being selective ligands for GABAA receptors, in particular having high affinity for the ... | 06/05/2007 |
| 7205304 | Sulfonyl-Derivatives as novel inhibitors of histone deacetylase This invention comprises the novel compounds of formula (I) wherein n, m, t, R1, R2, R3, R4, L, Q, X, Y, Z and have defined meanings, having histone deacetylase inhibiting enzymatic activity; their preparation, composition... | 04/17/2007 |
| 7176310 | Pyrimidinecarboxamide derivatives and their use as anti-inflammatory agents This invention is directed to compound of the following formula (I): wherein R1, R2, R3 and R4 are as described herein. These compounds and pharmaceutical compositions ... | 02/13/2007 |
| 7125996 | Fluorescent probes for use in protein kinase inhibitor binding assay The invention provides methods relating to a novel screening assay format that can be applied to broad members of the protein kinase gene family. The assay uses a series of labeled, active site probes described herein that can be displaced by an inhibitor agent. The... | 10/24/2006 |
| 7087599 | Estrogen receptor modulators The present invention relates to compounds and derivatives thereof, their synthesis, and their use as estrogen receptor modulators. The compounds of the instant invention are ligands for estrogen receptors and as such may be useful for treatment or prevention of a v... | 08/08/2006 |
| 7087598 | Diamide invertebrate pest control agents containing a non-aromatic heterocyclic ring This invention provides compounds of Formula I, their N-oxides and agriculturally suitable salts wherein A and B are independently O or S; J is an optionally substituted 5- or 6-memebered nonaromatic heterocyclic ring; K is taken together with the two contiguous lin... | 08/08/2006 |
| 7018685 | Fluorinated aromatic compounds and the use of the same in liquid crystal mixtures The invention relates to fluorinated aromatics of the formula (I) where X is CH2, C═O, CF2, O or S, Y is H or F, with the proviso that Y has to be F when X is CH2 | 03/28/2006 |
| 6972297 | 2-Hydroxy-mutilin carbamate derivatives for antibacterial use 2-(S)-hydroxymutilin carbamate derivatives of formula (I), in which R1 is a 5- or 6-membered optionally substituted heteroaryl group; and R2 is vinyl or ethyl, are useful in the treatment of bacterial infections | 12/06/2005 |
| 6949557 | Hydroanthracene based compounds as anticancer agents The invention relates to the use of novel anthracene based compounds for the inhibition or prevention of the growth or multiplication of cancer cells, and to therapeutic compositions containing such compounds. The invention relates more specifically to the use of hy... | 09/27/2005 |
| 6872824 | Pyrimidine spirobifluorene oligomer for organic light-emitting device A fluorene-based pyrimidine-containing conjugated oligomer applied in six different layers in an OLED, respectively, used as an electron-transport emitting layer, an emitting layer, a host in the emitting layer, the ETL, a host in the electron-transport emitting lay... | 03/29/2005 |
| 6756375 | 10-Aryl-11h-benzo[b]fluorene derivatives and analogs for medicinal use The invention provides for a non-steroidal compound having the formula wherein Re and ′Re are OH, optionally independently etherified or esterified; Z is —CH2— or —CH2C... | 06/29/2004 |
| 6737423 | Substituted heterocyclo-norbornylamino derivatives, processes for their preparation, their use as medicaments or diagnostics, and medicaments comprising them Substituted heterocyclo-norbornylaminoderivatives having: a) an exo-configuration nitrogen and an endo-fused five-membered ring or six-membered ring of the formula (I) or b) an exo-configuration nitrogen and an exo-fused five-membered ring or six-membered ring of th... | 05/18/2004 |
| 6492355 | Adamantane derivatives The invention provides compounds of general formula ##STR1## in which m, A, R1 and Ar have the meanings defined in the specification; a process for their preparation; pharmaceutical compositions containing them; a process for preparing the phar... | 12/10/2002 |
| 6399620 | Cycloalkyl derivatives as inhibitors of bone resporption and vitronectin receptor antagonists There are described cycloalkyl derivatives of the formula (I) R1 --Y--A--B--D--E--F--G (I) in which R1, Y, A, B, D, E, F and G have the meaning indicated herein, their preparation and their use as medicaments. The compounds according to ... | 06/04/2002 |
| 6288123 | Therapeutic guanidines The present invention provides therapeutically useful substituted guanidines, and methods of treatment and pharmaceutical compositions that utilize or comprise one or more of such guanidines.... | 09/11/2001 |
| 6211189 | Amino-spiro-quinazoline compounds There are provided novel compounds of formula (I) ##STR1## wherein A represents an aromatic carbocyclic ring or a 5- or 6-membered heterocyclic aromatic ring containing 1 to 3 heteroatoms which may be the same or different and are selected from O, N and S... | 04/03/2001 |
| 6200981 | Pyrimidin derivatives The invention relates to new pharmaceutically active compounds which are are P2-purinoceptor 7-transmembrane (TM) G-protein coupled receptor antagonists, compositions containing them and processes for their preparation.... | 03/13/2001 |
| 6174924 | Therapeutic guanidines The present invention provides therapeutically useful substituted guanidines, and methods of treatment and pharmaceutical compositions that utilize or comprise one or more of such guanidines.... | 01/16/2001 |
| 6143791 | Therapeutic guanidines The present invention provides therapeutically useful substituted guanidines, and methods of treatment and pharmaceutical compositions that utilize or comprise one or more of such guanidines.... | 11/07/2000 |
| 6107297 | 2,4-Dithi(oxo)-pyrimidin-5-yl compounds bearing a tricyclic substituent useful as P2 purinoceptor antagonists The invention relates to new pharmaceutically active compounds which are P2-purinoceptor 7-transmembrane (TM) G-protein coupled receptor antagonists, compositions containing them and processes for their preparation.... | 08/22/2000 |
| 6060591 | Water-soluble fiber-reactive dyes, processes for their preparation, and their use The disclosed dyes (which are fiber-reactive and are useful for dyeing materials containing OH and/or carboxamide groups) are compounds of the formula (1) Fb--Zn (1) in which: Fb is the radical of vario... | 05/09/2000 |
| 6015900 | N-aminoalkylfluorenecarboxamides Disclosed are compounds of formula (I) or the pharmaceutically acceptable salts thereof wherein: ##STR1## G represents a group of the formula (a), (b) or (c) where Ra and Rb represent hydrogen, or organic or inorganic substituen... | 01/18/2000 |
| 5703235 | N-Aminoalkyl-2-anthracenecarboxamides; new dopamine receptor subtype specific ligands Disclosed are compounds of the formula: ##STR1## or the pharmaceutically acceptable acid addition salts thereof, wherein: R1, R2, R3, R4, R5, R6, R7, R8 and R | 12/30/1997 |
| 5659033 | N-aminoalkylfluorenecarboxamides; a new class of dopamine receptor subtype specific ligands Disclosed are compounds of the formula ##STR1## or the pharmaceutically acceptable salts thereof wherein: G represents a group of the formula ##STR2## where Ra and Rb represent hydrogen, or organic or inorganic substit... | 08/19/1997 |
| 5646269 | Method for oligonucleotide analog synthesis The present invention is directed to improved methods to synthesize oligonucleotide analogs having an acetal linkage, such as a 3',5'-formacetal (3' --O--CH2 --O-- 5'), 3',5'-thioformacetal (3' --S--CH2 --O-- 5') or an analogous 2',5... | 07/08/1997 |
| 5512575 | Methanoanthraceneyl methyl piperidinyl compounds Compounds of formula I or I', ##STR1## wherein X and Y are independently selected from hydrogen, halo, and (1-6C)alkoxy; R1 is selected from (A) (1-6C)alkyl; (B) phenyl and naphthyl or substituted versions thereof; (C) phenyl (1-3C)alkyl and na... | 04/30/1996 |
| 5503666 | Dyestuffs and their use in inks for ink-jet printing processes Novel dyestuffs have been found which are obtainable by reacting A) polyamines containing at least 2 primary or secondary amino groups with B) reactive compounds containing at least two groups which are reactive towards primary and secondary amines in an amount of ... | 04/02/1996 |
| 5463031 | Reactive dyestuffs Reactive dyestuffs of the formula ##STR1## in which the substituents have the meanings given in the description are highly suitable for the dyeing and printing of cellulose materials and nitrogen-containing materials. They produce dyeings and prints ... | 10/31/1995 |
| 5455246 | Piperidine derivatives Compounds of formula I, Ia or Ib and pharmaceutically acceptable salts thereof, useful in the treatment of neuropsychiatric disorders such as psychoses; pharmaceutical compositions comprising a compound of formula I and a pharmaceutically acceptable dilue... | 10/03/1995 |
| 5420255 | Process for the continuous reaction of halogenopyrimidines with amines A process for the continuous reaction of halogenopyrimidines with amines, a halogenopyrimidine and an aqueous amine solution or suspension being passed into a reactor and the reaction product being subsequently conducted away, is described, characterized ... | 05/30/1995 |
| 5399674 | Dyestuffs containing pyrimidine-carboxylic acid amide radical having fiber-reactive group, processes for their preparation and their use Fiber-reactive dyestuffs, processes for their preparation and their use Dyestuffs of the formula (1) are described ##STR1## The dyestuffs have fiber-reactive properties and dye materials containing hydroxy groups and/or containing carboxamide groups, in p... | 03/21/1995 |
| 5342927 | Reactive dyestuffs for the dyeing and printing of hydroxyl-or amino-containing materials Reactive dyestuffs of the formula ##STR1## in which X is ##STR2## and Z is a heterocyclic reactive group and the remaining groups have the meaning given in the description, are highly suitable for the dyeing and printing of hydroxyl- or ami... | 08/30/1994 |
| 5300642 | , -disubstituted aromatics and heteroaromatics as cognition enhancers Cognitive defeciencies or neurological dysfunction in mammals are treated with ,-disubstituted aromatic or heteroaromatic compounds. The compounds have the formula: ##STR1## or a salt thereof wherein X and Y are taken together to form a... | 04/05/1994 |
| 5256784 | Nonlineaphores and polymers incorporating such nonlineaphores Nonlinear-optic (NLO) compositions containing functionalized merocyanine dyes, such that the molecules, comprising the NLO-active compositions have a functional group at each end of the molecule and each functional group differing in reactivity, thus perm... | 10/26/1993 |
| 5173489 | ,-disubstituted aromatics and heteroaromatics as cognition enhancers Cognitive defeciencies or neurological dysfunction in mammals are treated with ,-disubstituted aromatic or heteroaromatic compounds. The compounds have the formula: ##STR1## or a salt thereof wherein X and Y are taken together to form a... | 12/22/1992 |
| 5164499 | Nitroaryl carbonyl compounds, nitrodihydroaryl carbonyl intermediates thereto, and processes Nitroaryl carbonyl Formula (IIA) compounds, their nitrodihydroaryl carbonyl Formula (I) intermediates, processes for preparing Formula (II) compounds, and a process for preparing Formula (I) compounds, wherein each process comprises the reaction of a nitr... | 11/17/1992 |
| 5147882 | Cyclophanes, pharmaceutical compositions containing these compounds and processes for preparing them Cyclophanes of the general formula ##STR1## wherein X1, X2, A, R and R1 to R4 are as defined herein, the enantiomers, diastereomers and addition salts thereof and, more particularly, for pharmaceutical use,... | 09/15/1992 |